Adenocarcinoma yebele

I-adenocarcinoma yamathambo ngumhlobo wesifo somhlaza, eqinisweni, i-tumor ebulalayo enama-epithelial cells. Namhlanje sisifo esiqhelanisiweyo kwisifo phakathi kwabasetyhini (aba-1 kwabangu-9 abasetyhini bagula kwiminyaka engama-20-90). Kwamazwe athuthukileyo, inani lezonyango zomhlaza zesifuba landa kakhulu emva kwee-1970. Kucatshangelwa ukuba isizathu saloo nto kubamabhinqa banamhlanje ixesha lokuncelisa ibele lancipha kakhulu, izinga lokuzalwa labantwana kwintsapho liye lancipha.

Iintlobo, iifenethi ye-adenocarcinoma ye-mammary gland

Kuza kubekho, kukho iindidi eziphambili ze-adenocarcinoma:

  1. Umhlaza weprotocoque . I-neoplasm ifumaneka ngqo kwi-duct mammary.
  2. Umhlaza weLobular (lobular). I-tumor ichaphazela i-lobules yebele (enye okanye ngaphezulu).

Kukho iintlobo ezi-5 ze-adenocarcinoma:

Iipropati eziphambili zeengxube zesisu zixhomekeke ngokuthe ngqo kumahluli weeseli zabo:

  1. Ukwahlukahlukana kakhulu kwe-mammoken adenocarcinoma igcina imisebenzi, isakhiwo sayo sifana nesakhiwo seesisu esakhayo.
  2. Ubunzima obuncinane okanye obuncinane ohlukileyo-isakhiwo esifanayo asibonakali.
  3. Undifferentiated - kunzima ukucacisa ukubambisana kwezicubu, kuthathwa njengesifo esibi kakhulu nesingozi.

Ukuxeliswa kwe-mamenocarcinoma yamathambo

Kukho izinto ezininzi ezichaphazela ukuxela, okuyinxalenye enkulu yokuphazamiseka kwesisu, oko kukuthi, ukukwazi ukunyusa ngokuphawulekayo kwaye kunikeze i-metastases. Ukuba i-tumor yafunyaniswa ngexesha elifanelekileyo kwaye ayizange ifinyelele ubukhulu obungaphezulu kwama-2 cm, ngoko ke ukubikezelwa kwimeko ezininzi kukho. Kwakhona izibonakaliso ezintle zi: ukungabikho kwemastastimase, i-tumor ayizange ikhule ibe zicubu, i-tumor ihluke kakhulu.

Unyango lwe-adenocarcinoma yesifuba lubandakanya ukukhutshwa okupheleleyo kokuchithwa kunye nenxalenye yezilwanyana ezinempilo okanye ukuxiliswa kwe-gland nge-X-ray. Kwindlela echaphazelekayo yomhlaza, ngaphezu kokuhlinzwa, i-set of procedures ikwabekwa kwakhona: umbane, i-hormonal kunye ne-chemotherapy.